MicroSPECT/CT and MicroPET Imaging of Human Breast Cancer Xenografts Expressing HER2 in Athymic Mice using 111In-and 64Cu-DOTA-Trastuzumab Fab

被引：0
|
作者：
Chan, C.
Scollard, D. A.
McLarty, K.
Smith, S.
Reilly, R. M.
机构：
[1] Univ Toronto, Dept Pharmaceut Sci, Toronto, ON, Canada
[2] Univ Toronto, Dept Med Imaging, Toronto, ON, Canada
[3] Toronto Gen Res Inst, Toronto, ON, Canada
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2009年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S477 / S477
页数：1
相关论文
共 50 条
  • [1] A comparison of 111In- or 64Cu-DOTA-trastuzumab Fab fragments for imaging subcutaneous HER2-positive tumor xenografts in athymic mice using microSPECT/CT or microPET/CT
    Conrad Chan
    Deborah A Scollard
    Kristin McLarty
    Serena Smith
    Raymond M Reilly
    EJNMMI Research, 1
  • [2] A comparison of 111In- or 64Cu-DOTA-trastuzumab Fab fragments for imaging subcutaneous HER2-positive tumor xenografts in athymic mice using microSPECT/CT or microPET/CT
    Chan, Conrad
    Scollard, Deborah A.
    McLarty, Kristin
    Smith, Serena
    Reilly, Raymond M.
    EJNMMI RESEARCH, 2011, 1 : 1 - 11
  • [3] 64Cu-DOTA-trastuzumab positron emission tomography imaging of HER2 in women with advanced breast cancer
    Mortimer, J. E.
    Conti, P.
    Shan, T.
    Carroll, M.
    Kofi, P.
    Colcher, D.
    Raubitschek, A. A.
    Bading, J. R.
    Miles, J.
    CANCER RESEARCH, 2012, 72
  • [4] 64Cu-DOTA-Trastuzumab PET Imaging in Patients with HER2-Positive Breast Cancer
    Tamura, Kenji
    Kurihara, Hiroaki
    Yonemori, Kan
    Tsuda, Hitoshi
    Suzuki, Junko
    Kono, Yuzuru
    Honda, Natsuki
    Kodaira, Makoto
    Yamamoto, Harukaze
    Yunokawa, Mayu
    Shimizu, Chikako
    Hasegawa, Koki
    Kanayama, Yousuke
    Nozaki, Satoshi
    Kinoshita, Takayuki
    Wada, Yasuhiro
    Tazawa, Shusaku
    Takahashi, Kazuhiro
    Watanabe, Yasuyoshi
    Fujiwara, Yasuhiro
    JOURNAL OF NUCLEAR MEDICINE, 2013, 54 (11) : 1869 - 1875
  • [5] 64Cu-DOTA-trastuzumab PET imaging and HER2 specificity of brain metastases in HER2-positive breast cancer patients
    Kurihara, Hiroaki
    Hamada, Akinobu
    Yoshida, Masayuki
    Shimma, Schuichi
    Hashimoto, Jun
    Yonemori, Kan
    Tani, Hitomi
    Miyakita, Yasuji
    Kanayama, Yousuke
    Wada, Yasuhiro
    Kodaira, Makoto
    Yunokawa, Mayu
    Yamamoto, Harukaze
    Shimizu, Chikako
    Takahashi, Kazuhiro
    Watanabe, Yasuyoshi
    Fujiwara, Yasuhiro
    Tamura, Kenji
    EJNMMI RESEARCH, 2015, 5
  • [6] 64Cu-DOTA-trastuzumab PET imaging and HER2 specificity of brain metastases in HER2-positive breast cancer patients
    Hiroaki Kurihara
    Akinobu Hamada
    Masayuki Yoshida
    Schuichi Shimma
    Jun Hashimoto
    Kan Yonemori
    Hitomi Tani
    Yasuji Miyakita
    Yousuke Kanayama
    Yasuhiro Wada
    Makoto Kodaira
    Mayu Yunokawa
    Harukaze Yamamoto
    Chikako Shimizu
    Kazuhiro Takahashi
    Yasuyoshi Watanabe
    Yasuhiro Fujiwara
    Kenji Tamura
    EJNMMI Research, 5
  • [7] Imaging of HER2/neu-positive BT-474 human breast cancer xenografts in athymic mice using 111In-trastuzumab (Herceptin) Fab fragments
    Tang, Y
    Wang, J
    Scollard, DA
    Mondal, H
    Holloway, C
    Kahn, HJ
    Reilly, RM
    NUCLEAR MEDICINE AND BIOLOGY, 2005, 32 (01) : 51 - 58
  • [8] 64Cu-DOTA-trastuzumab PET imaging for HER2-specific primary lesions of breast cancer
    Sasada, S.
    Kurihara, H.
    Kinoshita, T.
    Yoshida, M.
    Honda, N.
    Shimoi, T.
    Shimomura, A.
    Yunokawa, M.
    Yonemori, K.
    Shimizu, C.
    Hamada, A.
    Kanayama, Y.
    Watanabe, Y.
    Fujiwara, Y.
    Tamura, K.
    ANNALS OF ONCOLOGY, 2017, 28 (08) : 2028 - 2029
  • [9] Tumor uptake of 64Cu-DOTA-trastuzumab correlates with HER2 gene amplification in patients with metastatic breast cancer
    Bading, James
    Press, Michael
    Villalobos, Ivonne
    Frankel, Paul
    Park, Jinha
    Tran, Tri
    Carroll, Mary
    Poku, Erasmus
    Miles, Joshua
    Colcher, David
    Mortimer, Joanne
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [10] The feasibility study of 64Cu-DOTA-trastuzumab PET imaging in patients with HER2-positive breast cancer
    Yonemori, Kan
    Tamura, Kenji
    Kurihara, Hiroaki
    Kono, Yuzuru
    Arai, Yasuaki
    Wada, Yasuhiro
    Takahashi, Kazuhiro
    Hasegawa, Koki
    Watanabe, Yasuyoshi
    Fujiwara, Yasuhiro
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
12345